-
CHMP highlights: February 2021
CHMP highlights: February 2021
-
CHMP highlights: February 2021
CHMP highlights: February 2021
EMA’s human medicines committee (CHMP) recommended six medicines for approval at its 22-25 February 2021 meeting.
-
EMA issues guidance to address coronavirus variants
EMA issues guidance to address coronavirus variants
-
EMA issues guidance to address coronavirus variants
EMA issues guidance to address coronavirus variants
EMA has issued guidance for vaccine manufacturers planning to adapt COVID-19 vaccines to coronavirus (SARS-CoV-2) variants.
-
Global cooperation on COVID-19 medicine regulation
Global cooperation on COVID-19 medicine regulation
-
Global cooperation on COVID-19 medicine regulation
Global cooperation on COVID-19 medicine regulation
ICMRA workshops underline international medicine regulators' commitment to align their align approaches for regulation of COVID-19 vaccines and medicines
-
Public meeting on COVID-19 vaccines: Friday 26 March
Public meeting on COVID-19 vaccines: Friday 26 March
-
Public meeting on COVID-19 vaccines: Friday 26 March
Public meeting on COVID-19 vaccines: Friday 26 March
Apply now to join the virtual room during our third public meeting, about the approval, safety monitoring and expected impact of COVID-19 vaccines or watch live on the day.
